EXTENSIVE STAGE LUNG SMALL CELL CANCER
Clinical trials for EXTENSIVE STAGE LUNG SMALL CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE STAGE LUNG SMALL CELL CANCER trials appear
Sign up with your email to follow new studies for EXTENSIVE STAGE LUNG SMALL CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough-to-treat lung cancer: tarlatamab trial targets patients with limited options
Disease control Recruiting nowThis study tests a drug called tarlatamab in 48 people with extensive-stage small cell lung cancer who have already tried one standard treatment. The drug is given through a vein and aims to control the cancer and help patients live longer. The main goal is to see how many patien…
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CANCER
Phase: PHASE2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated May 26, 2026 10:59 UTC
-
New drug combo aims to boost immune attack on tough lung cancer
Disease control Recruiting nowThis study tests a new drug called ivonescimab, which helps the immune system fight cancer and blocks tumor blood vessel growth. About 60 adults with advanced small cell lung cancer who haven't had treatment will get ivonescimab plus standard chemo. The goal is to find the best d…
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CANCER
Phase: PHASE2 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC